Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | AKTX | AMGN | GILD | BIIB | CELG |
Company | Akari Therapeutics ADR | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 1.5400 | 274.18 | 65.32 | 215.56 | 108.01 |
High | 1.8541 | 279.84 | 65.89 | 218.66 | 108.59 |
Low | 1.5136 | 273.38 | 64.97 | 214.70 | 107.27 |
Last | 1.7000 | 277.37 | 65.51 | 216.13 | 108.24 |
Change | +0.1600 | +3.43 | +0.31 | +1.31 | +0.11 |
% Change | +10.39% | +1.25% | +0.48% | +0.61% | +0.10% |
Volume | 163,003 | 2,322,158 | 7,169,043 | 915,743 | 191,230,496 |
20-Day Average Volume | 21,680 | 2,242,948 | 7,430,602 | 1,329,677 | 16,188,930 |
Previous Close | 1.5400 | 273.94 | 65.20 | 214.82 | 108.13 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | No |
Technicals | |||||
20-Day Moving Average | 1.2751 | 269.69 | 67.33 | 202.01 | 108.17 |
20-Day Raw Stochastic | 80.16% | 87.11% | 13.02% | 90.72% | 63.25% |
20-Day Relative Strength | 54.50% | 52.79% | 32.15% | 55.73% | 64.69% |
Weighted Alpha | -61.27 | +14.56 | -21.43 | -30.12 | +46.30 |
Today's Opinion | 72% Sell | 24% Sell | 100% Sell | 56% Sell | 100% Buy |
Previous Opinion | 80% Sell | 40% Sell | 100% Sell | 56% Sell | 100% Buy |
Last Month's Opinion | 100% Sell | 8% Sell | 88% Sell | 100% Sell | 100% Buy |
Performance | |||||
5-Days | |||||
%Chg | +42.86% since 04/24/24 | +1.60% since 04/24/24 | -2.34% since 04/24/24 | +7.00% since 04/24/24 | -1.97% since 11/13/19 |
Low | 1.1700 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 198.11 on 04/25/24 | 107.27 on 11/20/19 |
High | 1.8541 on 05/01/24 | 279.84 on 05/01/24 | 67.90 on 04/25/24 | 218.86 on 04/29/24 | 110.53 on 11/14/19 |
1-Month | |||||
%Chg | +12.58% since 04/01/24 | -2.00% since 04/01/24 | -10.11% since 04/01/24 | +0.61% since 04/01/24 | +5.14% since 10/18/19 |
Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
High | 1.8541 on 05/01/24 | 283.91 on 04/02/24 | 72.85 on 04/02/24 | 218.86 on 04/29/24 | 110.70 on 11/13/19 |
3-Month | |||||
%Chg | -34.94% since 02/01/24 | -14.54% since 02/01/24 | -16.18% since 02/01/24 | -12.79% since 02/01/24 | +13.63% since 08/20/19 |
Low | 1.0775 on 04/17/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
High | 2.7400 on 02/02/24 | 329.72 on 02/05/24 | 77.99 on 02/02/24 | 246.44 on 02/07/24 | 110.70 on 11/13/19 |
6-Month | |||||
%Chg | -52.65% since 11/01/23 | +6.34% since 11/01/23 | -18.31% since 11/01/23 | -9.80% since 11/01/23 | +14.14% since 05/20/19 |
Low | 1.0775 on 04/17/24 | 260.52 on 11/21/23 | 64.63 on 04/26/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
High | 3.6850 on 11/06/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
Key Statistics | |||||
Market Capitalization, $K | 12,202 | 146,934,848 | 81,179,024 | 31,277,148 | 77,035,920 |
Shares Outstanding, K | 7,924 | 536,376 | 1,245,077 | 145,597 | 711,714 |
Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
Annual Net Income | -10,010,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
Last Quarter Sales | 0 | 8,196,000,000 | 6,686,000,000 | 2,290,500,000 | 4,520,000,000 |
Last Quarter Net Income | -5,680,000 | 767,000,000 | -4,170,000,000 | 393,400,000 | 1,691,000,000 |
60-Month Beta | 0.96 | 0.58 | 0.19 | -0.02 | 1.41 |
Per-Share Information | |||||
Most Recent Earnings | N/A on 09/27/22 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
Latest Earnings Date | 05/06/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.82 | 16.36 | 14.37 | 10.99 |